Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
October 24th, 2025: New Study Links Ozempic to Potential Risk of Vision Loss A new study has identified a possible association between Ozempic and non-arteritic anterior ischemic optic neuropathy (NAION), a rare eye condition that can cause sudden and permanent vision loss
10.1016/j.mce.2023.112013 59 ShaoY.-Q.WangY.-C.WangL.RuanH.-Z.LiuY.-F.ZhangT.-H.et al (2024)
Expanded Clinical Pathways Category 1 status would provide clearer regulatory footing and could enable structured, compliant prescribing pathways
however, patients and clinicians should verify the current status directly with the trial sponsor or via ClinicalTrials
Product Benchmarking 8.5.1.4
You have 180 days to file an internal appeal
.jpg)
US$ 26.39
US$ 22.14
US$ 28.50
US$ 21.72
US$ 22.24
US$ 29.62
